Pn-MAPS30plus

N/A

Report date: 2026/02/26 20:00:22

Base Information

Drug NamePn-MAPS30plus
Drug Alias NamePneumococcal 30+ valent vaccine (GlaxoSmithKline)GSK-5459248
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumonia, Bacterial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsPneumonia, Bacterial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A